Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Raetz

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Blood Advances|April 15, 2026
Adding Induction Intrathecal Cytarabine in Newly Diagnosed CNS2 B-Acute Lymphoblastic Leukemia Does Not Improve OutcomesCathy A Lee-Miller, John A Kairalla, Emily Hibbitts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group StudySarah Alexander, John A Kairalla, Sumit Gupta, et al.
Research Square|July 28, 2023
Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in ChildrenCarolin Escherich, Wenan Chen, Yizhen Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology groupNyla A Heerema, Andrew J Carroll, Meenakshi Devidas, et al.
Blood|March 6, 2024
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in childrenCarolin S Escherich, Wenan Chen, Yizhen Li, et al.
Blood Advances|December 28, 2022
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemiaCarolin Escherich, Wenan Chen, Satoshi Miyamoto, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2016
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1Vilmarie Rodriguez, John Kairalla, Wanda L Salzer, et al.
Blood|July 1, 2015
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232Michael J Borowitz, Brent L Wood, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2023
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First RelapseLaura E Hogan, Patrick A Brown, Lingyun Ji, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Blood Advances|April 15, 2026
Adding Induction Intrathecal Cytarabine in Newly Diagnosed CNS2 B-Acute Lymphoblastic Leukemia Does Not Improve OutcomesCathy A Lee-Miller, John A Kairalla, Emily Hibbitts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group StudySarah Alexander, John A Kairalla, Sumit Gupta, et al.
Research Square|July 28, 2023
Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in ChildrenCarolin Escherich, Wenan Chen, Yizhen Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology groupNyla A Heerema, Andrew J Carroll, Meenakshi Devidas, et al.
Blood|March 6, 2024
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in childrenCarolin S Escherich, Wenan Chen, Yizhen Li, et al.
Blood Advances|December 28, 2022
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemiaCarolin Escherich, Wenan Chen, Satoshi Miyamoto, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2016
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1Vilmarie Rodriguez, John Kairalla, Wanda L Salzer, et al.
Blood|July 1, 2015
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232Michael J Borowitz, Brent L Wood, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2023
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First RelapseLaura E Hogan, Patrick A Brown, Lingyun Ji, et al.
Pageof 16